ストックスクリーナーアプリを入手
2.69
0.37%
0.02
前日終値:
$2.67
開ける：
$2.65
24時間の取引高:
23,171
Relative Volume:
0.18
時価総額：
$7.90M
収益：
$4.88M
当期純損益:
$-3.66M
株価収益率:
-1.753
EPS:
-1.5345
ネットキャッシュフロー:
$-2.80M
1週間 パフォーマンス:
+6.35%
1か月 パフォーマンス:
+14.53%
6か月 パフォーマンス:
-21.18%
1年 パフォーマンス:
-6.94%
1日の値動き範囲:
$2.481
$2.74
1週間の範囲:
$2.34
$2.74
52週間の値動き範囲:
$2.11
$10.16
Biomerica Inc Stock (BMRA) Company Profile
BMRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.68 | 7.87M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
126.88 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.52 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.05 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.61 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times
Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com
Medicare sets $300 price for new food-trigger test to ease IBS pain - Stock Titan
Why Biomerica Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Verified Technical Trade Signals - Улправда
Biomerica stockholders approve key proposals at annual meeting - MSN
Will Biomerica Inc. stock attract more institutional investorsTrade Signal Summary & Expert Verified Movement Alerts - Улправда
Market Review: Is Biomerica Inc. stock a safe haven assetMarket Activity Recap & Scalable Portfolio Growth Methods - Улправда
Will Biomerica Inc. stock recover faster than marketWeekly Market Report & Consistent Income Trade Ideas - Улправда
Can Biomerica Inc. stock maintain operating marginsTrade Volume Report & Stock Portfolio Risk Management - Улправда
Is Biomerica Inc. stock a safe haven assetJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - Улправда
Biomerica Earnings Notes - Trefis
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
Biomerica Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Egyptian drug authority approves Biomerica’s cancer screening portfolio By Investing.com - Investing.com Australia
Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt - GuruFocus
Egyptian drug authority approves Biomerica’s cancer screening portfolio - Investing.com
Biomerica, Inc. Receives Authorization from Egyptian Drug Authority for Comprehensive Cancer and Chronic Disease Screening Portfolio - Quiver Quantitative
Biomerica (NASDAQ:BMRA) versus ProKidney (NASDAQ:PROK) Critical Review - Defense World
Retail Trends: Why Biomerica Inc stock is recommended by analystsRisk Management & Target Return Focused Stock Picks - BỘ NỘI VỤ
Why Biomerica Inc. stock is recommended by analystsJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
Is Biomerica Inc. stock a good choice for value investorsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Biomerica Expands Contract Manufacturing Services - Orange County Business Journal
Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly - MarketScreener
Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeu - GuruFocus
Biomerica, Inc. Announces Positive Results from Multicenter Clinical Trial on inFoods® IBS Dietary Therapy - Quiver Quantitative
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - The Manila Times
Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Biomerica Inc. stock appeals to analystsMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Biomerica Inc. stock vulnerable to regulatory risksAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
What momentum shifts mean for Biomerica Inc.Portfolio Value Report & Safe Entry Momentum Tips - newser.com
Is Biomerica Inc. stock ready for a breakoutQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Biomerica Inc. stock trendline breakdown2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Can machine learning forecast Biomerica Inc. recovery2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
0.98%
大文字化:
|
ボリューム (24 時間):